S&P 500 7,358.22 â–ŧ 7.24 (-0.10%) DOW 51,848.90 ▲ 182.06 (+0.35%) NASDAQ 25,476.63 â–ŧ 110.41 (-0.43%) US Markets Closed â€ĸ 02:54 AM ET

MASI

Masimo Corporation

Price Chart
Latest Quote

$179.95

Current Price
Open $179.95
Day High $179.99
Day Low $179.95
Volume 3,089,485
Fetched: 2026-06-25T06:54:49
Stock Information
Shares Outstanding 52.37M
Total Debt $485.90M
Cash Equivalents $124.60M
Revenue $1.56B
Net Income $216.80M
Sector Healthcare
Industry Medical Devices
Market Cap $9.42B
P/E Ratio 44.43
EPS (TTM) $4.05
Exchange NGM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$9.78B
Sales$1.56B
Income$216.80M
Book/sh$15.06
Cash/sh$2.38
Employees2K
Financial Ratios
Quick Ratio1.27
Current Ratio2.67
Debt/Eq61.59
Returns & Margins
ROA10.20%
ROE24.99%
Gross Margin61.63%
Operating Margin23.61%
Profit Margin4.90%
Ownership
Insider Ownership6.21%
Institutional Ownership104.78%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E26.87
PEG4.83
P/S6.05
P/B11.94
Analyst Data
Recommendationhold
Target Price$180.00
Technical Indicators
SMA20$179.01
SMA50$178.68
SMA200$156.41
RSI75.45
ATR0.2825
Shares Float44.31M
Short Float7.34%
Short Ratio3.84
Volatility1.10
Performance History
Week+0.63%
Month+0.86%
Quarter+2.54%
6 Months+28.75%
YTD+41.25%
Year+7.75%
3 Years+9.61%
5 Years-13.94%
10 Years+258.68%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-12 $179.95 0
2026-06-11 $179.95 0
2026-06-10 $179.95 0
2026-06-09 $179.95 3,160,101
2026-06-08 $179.94 1,267,415
2026-06-05 $178.82 630,224
2026-06-04 $178.90 951,947
2026-06-03 $178.78 844,301
2026-06-02 $178.73 1,021,276
2026-06-01 $178.59 668,471
2026-05-29 $178.45 823,542
2026-05-28 $178.45 1,292,193
2026-05-27 $178.78 790,341
2026-05-26 $178.67 910,626
About Masimo Corporation

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $581,700,000 $600,900,000 $509,900,000 $977,000,000
Cost Of Revenue $581,700,000 $600,900,000 $509,900,000 $977,000,000
Total Revenue $1,526,900,000 $1,395,200,000 $1,275,500,000 $2,035,800,000
Operating Revenue $1,526,900,000 $1,395,200,000 $1,275,500,000 $2,035,800,000
Expenses
Interest Expense $33,200,000 $41,200,000 $47,100,000 $25,700,000
Total Expenses $1,214,100,000 $1,331,700,000 $1,091,700,000 $1,825,800,000
Other Income Expense $-10,400,000 $-4,900,000 $-26,600,000 $7,300,000
Net Non Operating Interest Income Expense $-29,800,000 $-36,800,000 $-44,200,000 $-23,900,000
Interest Expense Non Operating $33,200,000 $41,200,000 $47,100,000 $25,700,000
Operating Expense $632,400,000 $730,800,000 $581,800,000 $848,800,000
Other Non Operating Income Expenses - - - -
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $207,700,000 $16,200,000 $107,700,000 $143,500,000
Net Interest Income $-29,800,000 $-36,800,000 $-44,200,000 $-23,900,000
Interest Income $3,400,000 $4,400,000 $2,900,000 $1,800,000
Normalized Income $215,624,800 $19,840,700 $133,049,800 $138,083,400
Net Income From Continuing And Discontinued Operation $-151,500,000 $-304,900,000 $81,500,000 $143,500,000
Total Operating Income As Reported $310,000,000 $63,000,000 $166,000,000 $210,000,000
Net Income Common Stockholders $-151,500,000 $-304,900,000 $81,500,000 $143,500,000
Net Income $-151,500,000 $-304,900,000 $81,500,000 $143,500,000
Net Income Including Noncontrolling Interests $-151,500,000 $-304,900,000 $81,500,000 $143,500,000
Net Income Discontinuous Operations $-359,200,000 $-321,100,000 $-26,200,000 -
Net Income Continuous Operations $207,700,000 $16,200,000 $107,700,000 $143,500,000
Pretax Income $272,600,000 $21,800,000 $113,000,000 $193,400,000
Special Income Charges $-2,800,000 $-500,000 $-17,800,000 $0
Interest Income Non Operating $3,400,000 $4,400,000 $2,900,000 $1,800,000
Operating Income $312,800,000 $63,500,000 $183,800,000 $210,000,000
Gross Profit $945,200,000 $794,300,000 $765,600,000 $1,058,800,000
Per Share
Diluted EPS $-2.83 $-5.72 $1.51 $2.60
Basic EPS $-2.83 $-5.72 $1.54 $2.68
Other
Tax Effect Of Unusual Items $-2,475,200 $-1,259,300 $-1,250,200 $1,883,400
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $355,000,000 $116,400,000 $225,600,000 $347,900,000
Total Unusual Items $-10,400,000 $-4,900,000 $-26,600,000 $7,300,000
Total Unusual Items Excluding Goodwill $-10,400,000 $-4,900,000 $-26,600,000 $7,300,000
Reconciled Depreciation $38,800,000 $48,500,000 $38,900,000 $136,100,000
EBITDA (Bullshit earnings) $344,600,000 $111,500,000 $199,000,000 $355,200,000
EBIT $305,800,000 $63,000,000 $160,100,000 $219,100,000
Diluted Average Shares $54,200,000 $53,300,000 $54,100,000 $55,200,000
Basic Average Shares $53,600,000 $53,300,000 $52,800,000 $53,600,000
Diluted NI Availto Com Stockholders $-151,500,000 $-304,900,000 $81,500,000 $143,500,000
Tax Provision $64,900,000 $5,600,000 $5,300,000 $49,900,000
Other Special Charges $2,800,000 $500,000 $17,800,000 -
Gain On Sale Of Security $-7,600,000 $-4,400,000 $-8,800,000 $7,300,000
Research And Development $126,400,000 $182,200,000 $130,500,000 $191,400,000
Selling General And Administration $506,000,000 $548,600,000 $451,300,000 $657,400,000
Impairment Of Capital Assets - $304,000,000 $10,000,000 $0
Fetched: 2026-06-10
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $568,100,000 $893,600,000 $304,800,000 $170,900,000
Total Assets $1,698,900,000 $2,625,700,000 $3,041,500,000 $3,210,600,000
Total Non Current Assets $772,900,000 $1,399,900,000 $1,809,600,000 $1,902,000,000
Other Non Current Assets $5,300,000 $622,500,000 $8,900,000 $11,300,000
Non Current Prepaid Assets $14,300,000 $14,500,000 $17,000,000 $13,700,000
Non Current Deferred Assets $141,200,000 $144,700,000 $130,500,000 $121,300,000
Non Current Deferred Taxes Assets $114,200,000 $118,400,000 $107,200,000 $102,500,000
Non Current Accounts Receivable $64,400,000 $78,900,000 $88,400,000 $82,500,000
Financial Assets $1,000,000 $6,200,000 $11,400,000 $19,300,000
Investmentin Financial Assets $0 $2,000,000 $2,700,000 $0
Goodwill And Other Intangible Assets $153,100,000 $158,300,000 $1,060,000,000 $1,168,000,000
Other Intangible Assets $52,100,000 $61,600,000 $652,300,000 $722,600,000
Current Assets $926,000,000 $1,225,800,000 $1,231,900,000 $1,308,600,000
Other Current Assets $2,900,000 $2,300,000 $7,500,000 $3,600,000
Assets Held For Sale Current $1,000,000 $420,800,000 $0 -
Restricted Cash $0 $2,700,000 $3,000,000 $2,400,000
Prepaid Assets $62,000,000 $41,900,000 $92,400,000 $93,600,000
Inventory $380,300,000 $294,800,000 $545,000,000 $501,000,000
Receivables $327,500,000 $339,700,000 $421,000,000 $505,100,000
Other Receivables $30,800,000 $38,000,000 $36,900,000 $32,400,000
Taxes Receivable $20,900,000 $18,500,000 $28,600,000 $26,800,000
Accounts Receivable $260,900,000 $268,900,000 $348,200,000 $445,900,000
Allowance For Doubtful Accounts Receivable $-4,500,000 $-3,500,000 $-4,800,000 $-7,700,000
Gross Accounts Receivable $265,400,000 $272,400,000 $353,000,000 $453,600,000
Cash Cash Equivalents And Short Term Investments $152,300,000 $123,600,000 $163,000,000 $202,900,000
Cash And Cash Equivalents $152,300,000 $123,600,000 $163,000,000 $202,900,000
Notes Receivable - - - -
Debt
Net Debt $372,000,000 $605,700,000 $743,000,000 $753,800,000
Total Debt $559,300,000 $762,300,000 $970,000,000 $1,028,800,000
Long Term Debt And Capital Lease Obligation $544,900,000 $737,600,000 $917,500,000 $995,000,000
Long Term Debt $518,000,000 $714,300,000 $871,700,000 $941,600,000
Current Debt And Capital Lease Obligation $14,400,000 $24,700,000 $52,500,000 $33,800,000
Current Debt $6,300,000 $15,000,000 $34,300,000 $15,100,000
Other Current Borrowings $6,300,000 $15,000,000 $34,300,000 $15,100,000
Liabilities
Total Liabilities Net Minority Interest $977,700,000 $1,573,800,000 $1,676,700,000 $1,871,700,000
Total Non Current Liabilities Net Minority Interest $606,100,000 $956,100,000 $1,112,900,000 $1,241,700,000
Other Non Current Liabilities $7,000,000 $5,800,000 $7,900,000 $9,100,000
Liabilities Heldfor Sale Non Current $100,000 $170,700,000 - -
Tradeand Other Payables Non Current $30,900,000 $23,700,000 $39,900,000 $38,900,000
Non Current Deferred Liabilities $23,200,000 $18,300,000 $138,100,000 $188,600,000
Non Current Deferred Taxes Liabilities $200,000 $200,000 $111,700,000 $163,600,000
Current Liabilities $371,600,000 $617,700,000 $563,800,000 $630,000,000
Other Current Liabilities $4,700,000 $228,500,000 $6,700,000 $6,100,000
Current Deferred Liabilities $38,500,000 $43,800,000 $37,400,000 $36,000,000
Payables And Accrued Expenses $230,300,000 $242,000,000 $404,600,000 $464,800,000
Payables $165,900,000 $164,600,000 $305,900,000 $353,200,000
Total Tax Payable $39,400,000 $30,300,000 $50,200,000 $72,400,000
Income Tax Payable $16,700,000 $12,400,000 $16,100,000 $32,100,000
Accounts Payable $103,000,000 $129,000,000 $251,500,000 $276,800,000
Equity
Common Stock Equity $721,200,000 $1,051,900,000 $1,364,800,000 $1,338,900,000
Total Equity Gross Minority Interest $721,200,000 $1,051,900,000 $1,364,800,000 $1,338,900,000
Stockholders Equity $721,200,000 $1,051,900,000 $1,364,800,000 $1,338,900,000
Gains Losses Not Affecting Retained Earnings $-12,500,000 $-108,200,000 $-45,300,000 $11,500,000
Other Equity Adjustments $-12,500,000 $-108,200,000 $-45,300,000 $11,500,000
Retained Earnings $1,339,400,000 $1,490,900,000 $1,795,800,000 $1,714,300,000
Other
Treasury Shares Number $22,000,000 $19,500,000 $19,500,000 $19,500,000
Ordinary Shares Number $52,100,000 $53,600,000 $52,841,259 $52,500,000
Share Issued $74,100,000 $73,100,000 $72,341,259 $72,000,000
Tangible Book Value $568,100,000 $893,600,000 $304,800,000 $170,900,000
Invested Capital $1,245,500,000 $1,781,200,000 $2,270,800,000 $2,295,600,000
Working Capital $554,400,000 $608,100,000 $668,100,000 $678,600,000
Capital Lease Obligations $35,000,000 $33,000,000 $64,000,000 $72,100,000
Total Capitalization $1,239,200,000 $1,766,200,000 $2,236,500,000 $2,280,500,000
Treasury Stock $1,534,900,000 $1,169,200,000 $1,169,200,000 $1,169,200,000
Additional Paid In Capital $929,100,000 $838,300,000 $783,400,000 $782,200,000
Capital Stock $100,000 $100,000 $100,000 $100,000
Common Stock $100,000 $100,000 $100,000 $100,000
Preferred Stock $0 $0 $0 $0
Non Current Deferred Revenue $23,000,000 $18,100,000 $26,400,000 $25,000,000
Long Term Capital Lease Obligation $26,900,000 $23,300,000 $45,800,000 $53,400,000
Current Deferred Revenue $38,500,000 $43,800,000 $37,400,000 $36,000,000
Current Capital Lease Obligation $8,100,000 $9,700,000 $18,200,000 $18,700,000
Pensionand Other Post Retirement Benefit Plans Current $83,700,000 $78,700,000 $62,600,000 $89,300,000
Current Accrued Expenses $64,400,000 $77,400,000 $98,700,000 $111,600,000
Dueto Related Parties Current $23,500,000 $5,300,000 $4,200,000 $4,000,000
Investments And Advances $5,900,000 $8,600,000 $9,900,000 $13,800,000
Other Investments $5,900,000 $6,600,000 $7,200,000 $13,800,000
Goodwill $101,000,000 $96,700,000 $407,700,000 $445,400,000
Net PPE $387,700,000 $366,200,000 $483,500,000 $472,100,000
Accumulated Depreciation $-316,200,000 $-265,100,000 $-262,400,000 $-201,500,000
Gross PPE $703,900,000 $631,300,000 $745,900,000 $673,600,000
Leases $34,300,000 $31,200,000 $37,500,000 $32,300,000
Construction In Progress $24,500,000 $29,000,000 $59,200,000 $50,600,000
Other Properties $237,200,000 $178,300,000 $162,400,000 $131,000,000
Machinery Furniture Equipment $208,400,000 $201,600,000 $269,600,000 $243,600,000
Buildings And Improvements $151,800,000 $143,500,000 $151,000,000 $151,000,000
Land And Improvements $47,700,000 $47,700,000 $66,200,000 $65,100,000
Properties $0 $0 $0 $0
Finished Goods $205,700,000 $124,600,000 $285,300,000 $260,700,000
Work In Process $21,800,000 $19,200,000 $30,000,000 $30,400,000
Raw Materials $152,800,000 $151,000,000 $229,700,000 $209,900,000
Duefrom Related Parties Current $14,900,000 $14,300,000 $7,300,000 -
Employee Benefits - $9,000,000 $9,500,000 $10,100,000
Non Current Pension And Other Postretirement Benefit Plans - $9,000,000 $9,500,000 $10,100,000
Available For Sale Securities - $2,000,000 $2,700,000 -
Fetched: 2026-06-10
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $193,100,000 $158,100,000 $32,300,000 $-26,900,000
Operating Activities
Operating Cash Flow $217,800,000 $196,400,000 $94,100,000 $29,400,000
Cash From Discontinued Operating Activities $600,000 $33,900,000 $-5,500,000 -
Cash Flow From Continuing Operating Activities $217,200,000 $162,500,000 $99,600,000 $29,400,000
Operating Gains Losses $7,000,000 $96,800,000 $800,000 $500,000
Investing Activities
Capital Expenditure $-24,700,000 $-38,300,000 $-61,800,000 $-56,300,000
Investing Cash Flow $275,100,000 $-51,200,000 $-81,200,000 $-1,057,700,000
Cash From Discontinued Investing Activities $278,500,000 $-26,300,000 $-18,400,000 -
Cash Flow From Continuing Investing Activities $-3,400,000 $-24,900,000 $-62,800,000 $-1,057,700,000
Net Other Investing Changes $1,700,000 $-100,000 $-1,000,000 $-1,700,000
Financing Activities
Repurchase Of Capital Stock $-363,700,000 $0 $0 $-401,500,000
Issuance Of Capital Stock $71,400,000 $25,200,000 $7,000,000 $8,100,000
Financing Cash Flow $-520,700,000 $-125,600,000 $-57,100,000 $520,400,000
Cash From Discontinued Financing Activities $-2,600,000 $7,800,000 $13,900,000 -
Cash Flow From Continuing Financing Activities $-518,100,000 $-133,400,000 $-71,000,000 $520,400,000
Net Other Financing Charges $-21,700,000 $-11,800,000 $-12,900,000 $-34,700,000
Net Common Stock Issuance $-292,300,000 $25,200,000 $7,000,000 $-393,400,000
Common Stock Issuance $71,400,000 $25,200,000 $7,000,000 $8,100,000
Other
Repayment Of Debt $-1,281,500,000 $-235,800,000 $-238,400,000 $-135,400,000
Issuance Of Debt $1,077,400,000 $89,000,000 $173,300,000 $1,083,900,000
End Cash Position $153,300,000 $181,400,000 $168,200,000 $209,600,000
Beginning Cash Position $181,400,000 $168,200,000 $209,600,000 $748,400,000
Effect Of Exchange Rate Changes $-300,000 $-6,400,000 $2,800,000 $-30,900,000
Changes In Cash $-27,800,000 $19,600,000 $-44,200,000 $-507,900,000
Common Stock Payments $-363,700,000 $0 $0 $-401,500,000
Net Issuance Payments Of Debt $-204,100,000 $-146,800,000 $-65,100,000 $948,500,000
Net Short Term Debt Issuance $-204,100,000 $-146,800,000 $-65,100,000 $948,500,000
Short Term Debt Payments $-1,281,500,000 $-235,800,000 $-238,400,000 $-135,400,000
Short Term Debt Issuance $1,077,400,000 $89,000,000 $173,300,000 $1,083,900,000
Net Intangibles Purchase And Sale $-5,300,000 $-17,200,000 $-23,400,000 $-3,500,000
Purchase Of Intangibles $-5,300,000 $-17,200,000 $-23,400,000 -
Net PPE Purchase And Sale $200,000 $-7,600,000 $-38,400,000 $-52,800,000
Sale Of PPE $19,600,000 $13,500,000 $0 -
Purchase Of PPE $-19,400,000 $-21,100,000 $-38,400,000 $-52,800,000
Change In Working Capital $-89,900,000 $-14,900,000 $-37,100,000 $-261,800,000
Change In Other Working Capital $1,200,000 $14,000,000 $-5,800,000 $14,700,000
Change In Other Current Liabilities $5,100,000 $-5,600,000 $-400,000 $4,100,000
Change In Other Current Assets $17,000,000 $5,800,000 $35,100,000 $-12,300,000
Change In Payables And Accrued Expense $-18,300,000 $43,000,000 $-19,700,000 $38,900,000
Change In Accrued Expense $4,900,000 $37,800,000 $-11,500,000 $-25,400,000
Change In Payable $-23,200,000 $5,200,000 $-8,200,000 $64,300,000
Change In Account Payable $-27,100,000 $10,600,000 $-8,400,000 $60,500,000
Change In Tax Payable $3,900,000 $-5,400,000 $200,000 $3,800,000
Change In Income Tax Payable $3,900,000 $-5,400,000 $200,000 $3,800,000
Change In Inventory $-112,100,000 $-22,500,000 $-106,400,000 $-155,900,000
Change In Receivables $17,200,000 $-49,600,000 $60,100,000 $-151,300,000
Changes In Account Receivables $2,200,000 $-55,300,000 $54,400,000 $-144,100,000
Other Non Cash Items $3,000,000 $1,900,000 $1,900,000 $1,400,000
Stock Based Compensation $35,800,000 $36,100,000 $6,100,000 $47,700,000
Provisionand Write Offof Assets $3,000,000 $1,200,000 $1,100,000 $1,300,000
Deferred Tax $11,800,000 $-23,300,000 $-19,800,000 $-39,300,000
Deferred Income Tax $11,800,000 $-23,300,000 $-19,800,000 $-39,300,000
Depreciation Amortization Depletion $38,800,000 $48,500,000 $38,900,000 $136,100,000
Depreciation And Amortization $38,800,000 $48,500,000 $38,900,000 $136,100,000
Gain Loss On Sale Of PPE $7,000,000 $96,800,000 $800,000 $500,000
Net Income From Continuing Operations $207,700,000 $16,200,000 $107,700,000 $143,500,000
Interest Paid Supplemental Data - $39,100,000 $51,000,000 $23,000,000
Income Tax Paid Supplemental Data - $41,900,000 $54,400,000 $87,300,000
Net Business Purchase And Sale - $0 $7,500,000 $-999,700,000
Purchase Of Business - $0 - $-999,700,000
Asset Impairment Charge - $304,000,000 $10,000,000 $0
Amortization Cash Flow - $61,700,000 $54,400,000 -
Amortization Of Intangibles - $61,700,000 $54,400,000 -
Depreciation - $41,300,000 $43,900,000 -
Net Long Term Debt Issuance - - $-51,200,000 -
Long Term Debt Payments - - $-240,200,000 -
Long Term Debt Issuance - - $189,000,000 -
Sale Of Business - - $7,500,000 -
Net Investment Purchase And Sale - - - $0
Sale Of Investment - - - $0
Purchase Of Investment - - - -
Fetched: 2026-06-10